chr4-44686523-C-T

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_021927.3(GUF1):​c.748C>T​(p.Arg250Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00388 in 1,610,132 control chromosomes in the GnomAD database, including 17 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R250L) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0031 ( 1 hom., cov: 32)
Exomes 𝑓: 0.0040 ( 16 hom. )

Consequence

GUF1
NM_021927.3 missense

Scores

3
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:3

Conservation

PhyloP100: 0.805

Publications

3 publications found
Variant links:
Genes affected
GUF1 (HGNC:25799): (GTP binding elongation factor GUF1) This gene encodes a GTPase that triggers back-translocation of the elongating ribosome during mitochondrial protein synthesis. The protein contains a highly conserved C-terminal domain not found in other GTPases that facilitates tRNA binding. The encoded protein is thought to prevent misincorporation of amino acids in stressful, suboptimal conditions. An allelic variant in this gene has been associated with early infantile epileptic encephalopathy-40. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2016]
GNPDA2 (HGNC:21526): (glucosamine-6-phosphate deaminase 2) The protein encoded by this gene is an allosteric enzyme that catalyzes the reversible reaction converting D-glucosamine-6-phosphate into D-fructose-6-phosphate and ammonium. Variations of this gene have been reported to be associated with influencing body mass index and susceptibility to obesity. A pseudogene of this gene is located on chromosome 9. Alternative splicing results in multiple transcript variants that encode different protein isoforms. [provided by RefSeq, Aug 2012]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0038073063).
BP6
Variant 4-44686523-C-T is Benign according to our data. Variant chr4-44686523-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 445372.
BS2
High AC in GnomAd4 at 466 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
GUF1NM_021927.3 linkc.748C>T p.Arg250Cys missense_variant Exon 8 of 17 ENST00000281543.6 NP_068746.2 Q8N442

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
GUF1ENST00000281543.6 linkc.748C>T p.Arg250Cys missense_variant Exon 8 of 17 1 NM_021927.3 ENSP00000281543.5 Q8N442

Frequencies

GnomAD3 genomes
AF:
0.00307
AC:
466
AN:
151868
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000991
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00441
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.000755
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00505
Gnomad OTH
AF:
0.00336
GnomAD2 exomes
AF:
0.00234
AC:
585
AN:
250528
AF XY:
0.00231
show subpopulations
Gnomad AFR exome
AF:
0.000433
Gnomad AMR exome
AF:
0.00227
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.000742
Gnomad NFE exome
AF:
0.00403
Gnomad OTH exome
AF:
0.00278
GnomAD4 exome
AF:
0.00397
AC:
5784
AN:
1458146
Hom.:
16
Cov.:
30
AF XY:
0.00383
AC XY:
2776
AN XY:
725506
show subpopulations
African (AFR)
AF:
0.000540
AC:
18
AN:
33358
American (AMR)
AF:
0.00249
AC:
111
AN:
44602
Ashkenazi Jewish (ASJ)
AF:
0.0000384
AC:
1
AN:
26014
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39584
South Asian (SAS)
AF:
0.000314
AC:
27
AN:
85994
European-Finnish (FIN)
AF:
0.000844
AC:
45
AN:
53326
Middle Eastern (MID)
AF:
0.000522
AC:
3
AN:
5752
European-Non Finnish (NFE)
AF:
0.00484
AC:
5369
AN:
1109296
Other (OTH)
AF:
0.00347
AC:
209
AN:
60220
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.453
Heterozygous variant carriers
0
230
460
691
921
1151
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00307
AC:
466
AN:
151986
Hom.:
1
Cov.:
32
AF XY:
0.00299
AC XY:
222
AN XY:
74312
show subpopulations
African (AFR)
AF:
0.000988
AC:
41
AN:
41498
American (AMR)
AF:
0.00440
AC:
67
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.000755
AC:
8
AN:
10592
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00505
AC:
343
AN:
67898
Other (OTH)
AF:
0.00332
AC:
7
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
25
51
76
102
127
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00318
Hom.:
1
Bravo
AF:
0.00309
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00441
AC:
17
ESP6500AA
AF:
0.000454
AC:
2
ESP6500EA
AF:
0.00454
AC:
39
ExAC
AF:
0.00227
AC:
276
Asia WGS
AF:
0.000578
AC:
2
AN:
3476

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:3
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

not provided Uncertain:1Benign:2
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 20, 2017
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

GUF1: BP4, BS2 -

GUF1-related disorder Benign:1
Dec 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.10
BayesDel_addAF
Benign
-0.53
T
BayesDel_noAF
Benign
-0.53
CADD
Benign
22
DANN
Uncertain
0.98
DEOGEN2
Benign
0.11
T
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.37
FATHMM_MKL
Benign
0.15
N
LIST_S2
Uncertain
0.97
D
M_CAP
Benign
0.0058
T
MetaRNN
Benign
0.0038
T
MetaSVM
Benign
-1.0
T
MutationAssessor
Benign
1.9
L
PhyloP100
0.81
PrimateAI
Benign
0.26
T
PROVEAN
Uncertain
-2.4
N
REVEL
Benign
0.035
Sift
Benign
0.077
T
Sift4G
Benign
0.11
T
Polyphen
0.0010
B
Vest4
0.11
MVP
0.27
MPC
0.078
ClinPred
0.015
T
GERP RS
3.3
Varity_R
0.087
gMVP
0.40
Mutation Taster
=98/2
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.12
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs116062572; hg19: chr4-44688540; COSMIC: COSV99029373; API